149 related articles for article (PubMed ID: 16705085)
41. Fibrinogen Matsumoto I: a gamma 364 Asp-->His (GAT-->CAT) substitution associated with defective fibrin polymerization.
Okumura N; Furihata K; Terasawa F; Nakagoshi R; Ueno I; Katsuyama T
Thromb Haemost; 1996 Jun; 75(6):887-91. PubMed ID: 8822581
[TBL] [Abstract][Full Text] [Related]
42. Fibrinogen Mahdia: A congenitally abnormal fibrinogen characterized by defective fibrin polymerization.
Amri Y; Jouini H; Becheur M; Dabboubi R; Mahjoub B; Messaoud T; Sfar MT; Casini A; de Moerloose P; Toumi NEH
Haemophilia; 2017 Jul; 23(4):e340-e347. PubMed ID: 28594476
[TBL] [Abstract][Full Text] [Related]
43. [Functional analysis of heterozygous plasma dysfibrinogens derived from two families of gammaArg275Cys and three families of gammaArg275His, and haplotype analysis for these families].
Kamijyo Y; Hirota-Kawadobora M; Fujihara N; Wakabayashi S; Matsuda K; Yamauchi K; Terasawa F; Okumura N; Honda T
Rinsho Byori; 2009 Jul; 57(7):651-8. PubMed ID: 19708534
[TBL] [Abstract][Full Text] [Related]
44. In vitro expression demonstrates impaired secretion of the gammaAsn319, Asp320 deletion variant fibrinogen.
Kani S; Terasawa F; Lord ST; Tozuka M; Ota H; Okumura N; Katsuyama T
Thromb Haemost; 2005 Jul; 94(1):53-9. PubMed ID: 16113784
[TBL] [Abstract][Full Text] [Related]
45. The pleiotropic role of the fibrinogen gamma' chain in hemostasis.
Uitte de Willige S; Standeven KF; Philippou H; Ariëns RA
Blood; 2009 Nov; 114(19):3994-4001. PubMed ID: 19687509
[TBL] [Abstract][Full Text] [Related]
46. The presence of gamma' chain impairs fibrin polymerization.
Gersh KC; Nagaswami C; Weisel JW; Lord ST
Thromb Res; 2009 Jul; 124(3):356-63. PubMed ID: 19138790
[TBL] [Abstract][Full Text] [Related]
47. Fibrinogen variant BbetaD432A has normal polymerization but does not bind knob "B".
Bowley SR; Lord ST
Blood; 2009 Apr; 113(18):4425-30. PubMed ID: 19075185
[TBL] [Abstract][Full Text] [Related]
48. Fibrinogen Hillsborough: a novel gammaGly309Asp dysfibrinogen with impaired clotting.
Mullin JL; Brennan SO; Ganly PS; George PM
Blood; 2002 May; 99(10):3597-601. PubMed ID: 11986213
[TBL] [Abstract][Full Text] [Related]
49. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
Achyuthan KE; Dobson JV; Greenberg CS
Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
[TBL] [Abstract][Full Text] [Related]
50. Substitution (γ335Trp→Arg) in fibrinogen Fremantle causes diminished γ chain expression and increased sialic acid content.
Brennan SO; Davis RL
Thromb Haemost; 2010 Dec; 104(6):1274-6. PubMed ID: 20838743
[No Abstract] [Full Text] [Related]
51. Factor XIIIa cross-linking of the Marburg fibrin: formation of alpham.gamman-heteromultimers and the alpha-chain-linked albumin. gamma complex, and disturbed protofibril assembly resulting in acquisition of plasmin resistance relevant to thrombophila.
Sugo T; Nakamikawa C; Takebe M; Kohno I; Egbring R; Matsuda M
Blood; 1998 May; 91(9):3282-8. PubMed ID: 9558384
[TBL] [Abstract][Full Text] [Related]
52. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
Koopman J; Haverkate F; Briët E; Lord ST
J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
[TBL] [Abstract][Full Text] [Related]
53. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
[TBL] [Abstract][Full Text] [Related]
54. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
55. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
56. The polymerization pocket "a" within the carboxyl-terminal region of the gamma chain of human fibrinogen is adjacent to but independent from the calcium-binding site.
Côté HC; Pratt KP; Davie EW; Chung DW
J Biol Chem; 1997 Sep; 272(38):23792-8. PubMed ID: 9295325
[TBL] [Abstract][Full Text] [Related]
57. Analysis of the catalytic activity of human factor XIIIa by site-directed mutagenesis.
Hettasch JM; Greenberg CS
J Biol Chem; 1994 Nov; 269(45):28309-13. PubMed ID: 7961769
[TBL] [Abstract][Full Text] [Related]
58. Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness.
Standeven KF; Carter AM; Grant PJ; Weisel JW; Chernysh I; Masova L; Lord ST; Ariëns RA
Blood; 2007 Aug; 110(3):902-7. PubMed ID: 17435113
[TBL] [Abstract][Full Text] [Related]
59. Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Hematol; 2020 Sep; 112(3):331-340. PubMed ID: 32562089
[TBL] [Abstract][Full Text] [Related]
60. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
Matsuka YV; Medved LV; Migliorini MM; Ingham KC
Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
